News tagged with dutasteride

Sorry, no news articles match your request. Your search criteria may be too narrow.

Dutasteride

Dutasteride (trade name Avodart by GlaxoSmithKline) is a dual 5-a reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT).

Dutasteride is FDA approved for treatment of benign prostatic hyperplasia (BPH) and is also prescribed off-label for treatment of male pattern baldness (MPB).

This text uses material from Wikipedia, licensed under CC BY-SA